Alzheimer’s disease (AD) is the most common form of
dementia. It was first described by German neuropathologist and psychiatrist
Alois Alzheimer in 1906 and was named after him. AD is a neurodegenerative
disorder and is recognized to progress through three stages: preclinical, mild
cognitive impairment and dementia. In preclinical stage, the biomarkers such as
plasma amyloid beta measurement can be used as prognostic marker. A recent
study identified a set of lipid metabolites in blood plasma that showed 90%
accurate prediction of those who would go on to show cognitive impairment
within 3 years. In mild cognitive impairment, patients have cognitive deficits,
where the memory of recent facts and spatial orientation is affected but not
functional impairment. In AD dementia, a decline in two or more cognitive
domains have gradually progressed to the points that functioning at work or
daily activities such as speech is impaired. Currently there is no cure for the
disease. The medication is only symptomatic relief with adverse effects.
In China acupuncture is utilized to enhance memory and
recently is used to treat Alzheimer’s. Clinical studies recruited 20 AD
patients reported that acupuncture stimulation at the Baihui (GV 20), Shenshu
(BL 23), Xuehai (SP 10) and Geshu (BL 17) acupoints for 12 weeks was very
effective in improving AD symptoms judged by the scores of Alzheimer’s Disease
Assessment Scale-Cognitive Section. The biochemical study showed that the
concentration of isoprostane, a marker for peroxidation of fatty acid, was
significantly decreased in cerebrospinal fluid, blood and urine of patients
with AD after acupuncture treatments. Although this study had a small sample
size it showed acupuncture is a promising alternative therapy for Alzheimer’s
disease.
Reference:
H Zhu (2010) Zhongguo Zhen Jiu. 30(1):18-21. http://www.ncbi.nlm.nih.gov/pubmed/20353108
No comments:
Post a Comment